121 related articles for article (PubMed ID: 26832884)
1. Optimal Surgical Management for Occult Breast Carcinoma: A Meta-analysis.
Macedo FI; Eid JJ; Flynn J; Jacobs MJ; Mittal VK
Ann Surg Oncol; 2016 Jun; 23(6):1838-44. PubMed ID: 26832884
[TBL] [Abstract][Full Text] [Related]
2. Treatment outcomes and unfavorable prognostic factors in patients with occult breast cancer.
He M; Tang LC; Yu KD; Cao AY; Shen ZZ; Shao ZM; Di GH
Eur J Surg Oncol; 2012 Nov; 38(11):1022-8. PubMed ID: 22959166
[TBL] [Abstract][Full Text] [Related]
3. Surgical Management of the Axilla in Patients with Occult Breast Cancer (cT0 N+) After Neoadjuvant Chemotherapy.
Cohen BL; Collier AL; Kelly KN; Goel N; Kesmodel SB; Yakoub D; Moller M; Avisar E; Franceschi D; Macedo FI
Ann Surg Oncol; 2020 Jun; 27(6):1830-1841. PubMed ID: 31989360
[TBL] [Abstract][Full Text] [Related]
4. Best treatment options for occult breast cancer: A meta-analysis.
Wang R; Yang HX; Chen J; Huang JJ; Lv Q
Front Oncol; 2023; 13():1051232. PubMed ID: 37251927
[TBL] [Abstract][Full Text] [Related]
5. Treatment and survival of patients with occult breast cancer with axillary lymph node metastasis: a nationwide retrospective study.
Sohn G; Son BH; Lee SJ; Kang EY; Jung SH; Cho SH; Baek S; Lee YR; Kim HJ; Ko BS; Yu ; Lee JW; Ahn SH
J Surg Oncol; 2014 Sep; 110(3):270-4. PubMed ID: 24863883
[TBL] [Abstract][Full Text] [Related]
6. Routine completion axillary lymph node dissection for positive sentinel nodes in patients undergoing mastectomy is not associated with improved local control.
Crawford JD; Ansteth M; Barnett J; Glissmeyer M; Johnson NG
Am J Surg; 2013 May; 205(5):581-4; discussion 584. PubMed ID: 23592166
[TBL] [Abstract][Full Text] [Related]
7. Surgical management of early stage invasive breast cancer: a practice guideline.
McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
[TBL] [Abstract][Full Text] [Related]
8. Conservative axillary surgery in breast cancer patients undergoing mastectomy: long-term results.
Cowher MS; Grobmyer SR; Lyons J; O'Rourke C; Baynes D; Crowe JP
J Am Coll Surg; 2014 Apr; 218(4):819-24. PubMed ID: 24655877
[TBL] [Abstract][Full Text] [Related]
9. Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer?
Fu Y; Chung D; Cao MA; Apple S; Chang H
Ann Surg Oncol; 2014 Dec; 21(13):4109-23. PubMed ID: 25081336
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy.
FitzSullivan E; Bassett RL; Kuerer HM; Mittendorf EA; Yi M; Hunt KK; Babiera GV; Caudle AS; Black DM; Bedrosian I; Reyna C; Teshome M; Meric-Bernstam F; Hwang R
Ann Surg Oncol; 2017 Mar; 24(3):652-659. PubMed ID: 27822630
[TBL] [Abstract][Full Text] [Related]
11. Outcomes with and without axillary node dissection for node-positive lumpectomy and mastectomy patients.
Snow R; Reyna C; Johns C; Lee MC; Sun W; Fulp WJ; Kiluk JV; Laronga C
Am J Surg; 2015 Oct; 210(4):685-93. PubMed ID: 26210706
[TBL] [Abstract][Full Text] [Related]
12. Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes.
Bonneau C; Hequet D; Estevez JP; Pouget N; Rouzier R
Eur J Surg Oncol; 2015 Aug; 41(8):998-1004. PubMed ID: 25986854
[TBL] [Abstract][Full Text] [Related]
13. Omission of axillary lymph node dissection for clinically node negative early-stage breast cancer patients.
Kobayashi R; Shiraishi K; Iwase S; Ohtomo K; Nakagawa K
Breast Cancer; 2015 Nov; 22(6):657-63. PubMed ID: 24756246
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging facilitates breast conservation for occult breast cancer.
Olson JA; Morris EA; Van Zee KJ; Linehan DC; Borgen PI
Ann Surg Oncol; 2000 Jul; 7(6):411-5. PubMed ID: 10894136
[TBL] [Abstract][Full Text] [Related]
15. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
[TBL] [Abstract][Full Text] [Related]
16. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
17. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
[TBL] [Abstract][Full Text] [Related]
18. Management of contralateral axillary lymph node metastasis from breast cancer: a clinical dilemma.
Wang W; Yuan P; Wang J; Ma F; Zhang P; Li Q; Xu B
Tumori; 2014; 100(6):600-4. PubMed ID: 25688492
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcomes of occult breast carcinoma and prognostic analyses.
Wang J; Zhang YF; Wang X; Wang J; Yang X; Gao YQ; Fang Y
Chin Med J (Engl); 2013 Aug; 126(16):3026-9. PubMed ID: 23981605
[TBL] [Abstract][Full Text] [Related]
20. Effect of axillary lymph node dissection after sentinel lymph node biopsy on overall survival in patients with T1 or T2 node-positive breast cancer: report from the Korean Breast Cancer Society.
Park HS; Chae BJ; Song BJ; Jung SS; Han W; Nam SJ; Youn HJ; Ko BK; Kim DW;
Ann Surg Oncol; 2014 Apr; 21(4):1231-6. PubMed ID: 24318094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
